Rodríguez BS, Aguilar MJM; Leyva QAY, Prohías MJA

Language: Spanish
References: 9
Page: 115-119
PDF size: 518.80 Kb.

Text Extraction

To the Editor:

The epidemic of heart failure is spreading throughout the world. In this prestigious journal, Jerez Castro 1 made an exhaustive and accurate review of the availability of non-pharmacological alternatives for the treatment of heart failure; however, this disease keeps a high morbidity and mortality, decreases life quality and increases hospital admissions and health care costs.
In the pathophysiology of the different forms of presentation of pump failure: either acute or chronic, and heart failure with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF), there is a common element: increased left atrial (LA) pressure. The creation of an interatrial communication through percutaneous balloon atrial septostomy (PBAS) has emerged as an alternative therapy.

REFERENCES

1. Jerez Castro AM. Alternativas no farmacológicas en la insuficiencia o falla cardíaca. CorSalud [Internet]. 2020 [citado 10 Sept 2020];12(2):198-208. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/654/1156

2. Alkhouli M, Narins CR, Lehoux J, Knight PA, Waits B, Ling FS. Percutaneous decompression of the left ventricle in cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation. J Card Surg. 2016;31(3):177-82. DOI: https://doi.org/10.1111/jocs.12696

3. Bauer A, Khalil M, Lüdemann M, Bauer J, Esmaeili A, De-Rosa R, et al. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion. Clin Res Cardiol. 2018;107(9):845-57. DOI: https://doi.org/10.1007/s00392-018-1255-x

4. Bauer A, Khalil M, Schmidt D, Recla S, Bauer J, Esmaeili A, et al. Transcatheter left atrial decompression in patients with dilated cardiomyopathy: bridging to cardiac transplantation or recovery. Cardiol Young. 2019;29(3):355-62. DOI: https://doi.org/10.1017/s1047951118002433

5. Hasenfuß G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, et al. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): A multicentre, open-label, single-arm, phase 1 trial. Lancet. 2016;387(10025):1298-304. DOI: https://doi.org/10.1016/s0140-6736(16)00704-2

6. Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation. 2018;137(4):364-75. DOI: https://doi.org/10.1161/circulationaha.117.032094

7. Rodés-Cabau J, Bernier M, Amat-Santos IJ, Ben Gal T, Nombela-Franco L, García Del Blanco B, et al. Interatrial Shunting for Heart Failure: Early and late results from the first-in-human experience with the V-Wave system. JACC Cardiovasc Interv. 2018;11(22):2300-10. DOI: https://doi.org/10.1016/j.jcin.2018.07.001

8. Del Trigo M, Bergeron S, Bernier M, Amat-Santos IJ, Puri R, Campelo-Parada F, et al. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study. Lancet. 2016;387(10025):1290-7. DOI: https://doi.org/10.1016/s0140-6736(16)00585-7

9. Simard T, Labinaz M, Zahr F, Nazer B, Gray W, Hermiller J, et al. Percutaneous atriotomy for levoatrial-to-coronary sinus shunting in symptomatic heart failure: First-in-Human Experience. JACC Cardiovasc Interv. 2020;13(10):1236-47. DOI: https://doi.org/10.1016/j.jcin.2020.02.022